openPR Logo
Press release

Clinical Trials Market Upcoming Technology, Challenges, Trends, Growth, Key Players & Forecast - 2028

12-27-2018 06:33 AM CET | Health & Medicine

Press release from: Future Market Insights

Clinical Trials Market Upcoming Technology, Challenges,

Collaboration at Its Peak: Key Strategy of Manufacturers in Clinical Trials Market

For reducing economic burden, many companies are planning to shift their focus towards on-core business activities, thereby outsourcing their clinical trials activities to the CROs (contract research organizations). This in turn influences biotechnology and pharmaceutical companies for outsourcing clinical trials activities to the CROs in APAC. Major CROs are approached by the drug companies at a notable rate for close business collaboration, which in turn results in increasing number of consolidations by means of M7A in CRO industry.

Eli Lilly and Company: The clinical trials company has made an announcement regarding its collaboration with NextCure, Inc. for discovering and developing immuno-oncology therapies. This collaboration will mainly help in discovering new cancer targets using proprietary FIND-IO™ platform of NextCure, Inc. This in turn is likely to create ample growth opportunities for clinical trials market with increasing number of research activities probable to take place.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-384

Novo Nordisk A/S: The clinical trials company recently entered into a research collaboration with Embark Biotech ApS for discovering new treatments beneficial for obesity and its related metabolic pathologies by means of mechanisms, which increase energy expenditure. Clinical trials market is likely to witness major revenue contribution from the emerging development of the next-gen anti-obesity therapies by Novo Nordisk A/S and Embark Biotech ApS.
Sanofi Aventis A.S.: The clinical trials company lately introduced Aubagio®, which is a once-a-day oral medicine that is highly effective and convenient for Multiple Sclerosis diagnosed patients. Better diagnostic facilities and growing awareness is leading to new cases of Multiple Sclerosis. This proven clinical-efficiency can be taken up as a long-term treatment with safe and tolerable outcomes, thereby stimulating the need for further clinical trials.

India to Take a Major Toll in Clinical Trials Market

Developing economies such as India clinical trials market is expected to prove attractive markets owing to increasing availability of expert practitioners, growing government support with regards to development of the outsourcing hubs. Growing prevalence of metabolic disorders with rising number of patients suffering from obesity, metabolic disorders and are insulin resistant continues to offer growth opportunities for APAC clinical trials market. Lesser insurance coverage and growing medical expenses due to increasing presence of private hospitals is leading to rapidly increasing need for clinical trials for accessing free-of-cost high-quality healthcare. Reduced labor cost for the clinical operations personnel, lower recruitment costs, low costs related to handling of clinical trial supplies and growing focus on multiple orphan drugs further drives the growth of APAC clinical trials market.

Biopharmaceutical Companies to Significantly Drive Revenue Growth of Clinical Trials Market

Virtual development models are expected to provide new pathways for the clinical trials market in the near future with surging demand from the pharmaceutical companies. Introduction of new medications such as personalized medicine and growing demand for CROs for conducting clinical trials is expected to drive clinical trials market across the globe. Growing number of patients suffering from special diseases offers biopharmaceutical companies manufacturing opportunities, which in turn leads them to make heavy investments in clinical trials. Dearth of experts for the purpose of operating innovative and advanced CTMS solutions is likely to pose significant challenges for the clinical trials market.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-384

Bifurcation of Clinical Trials Market Is Done Based On Indication and Phases

On the basis of indication, clinical trials market is segmented into

Mental disorders
Gastrointestinal diseases
Cardio vascular system (CVS) diseases
Metabolic disorders
Dermatology
Infections
Central nervous system (CNS)
Musculoskeletal diseases
Congenital diseases
Genitourinary diseases
Cancer
Circulatory diseases
Autoimmune diseases
Ophthalmology
Blood disorders
Others

On the basis of phases, clinical trials market is segmented into

Phase IV
Phase III
Phase II
Phase I

ABOUT US:
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Future Market Insights
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trials Market Upcoming Technology, Challenges, Trends, Growth, Key Players & Forecast - 2028 here

News-ID: 1460928 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Clinical

Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia." Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures. Developments in Testing and Preference for Evidence based testing: There is also a rising number
Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical